211 related articles for article (PubMed ID: 30987717)
21. Dansylation metabolite assay: a simple and rapid method for sample amount normalization in metabolomics.
Wu Y; Li L
Anal Chem; 2014 Oct; 86(19):9428-33. PubMed ID: 25215550
[TBL] [Abstract][Full Text] [Related]
22. Development of Chemical Isotope Labeling Liquid Chromatography Orbitrap Mass Spectrometry for Comprehensive Analysis of Dipeptides.
Cheng Z; Li L
Anal Chem; 2023 Apr; 95(16):6629-6636. PubMed ID: 37039432
[TBL] [Abstract][Full Text] [Related]
23. Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.
Chen YT; Chen HW; Domanski D; Smith DS; Liang KH; Wu CC; Chen CL; Chung T; Chen MC; Chang YS; Parker CE; Borchers CH; Yu JS
J Proteomics; 2012 Jun; 75(12):3529-45. PubMed ID: 22236518
[TBL] [Abstract][Full Text] [Related]
24. Development of High-Performance Chemical Isotope Labeling LC-MS for Profiling the Carbonyl Submetabolome.
Zhao S; Dawe M; Guo K; Li L
Anal Chem; 2017 Jun; 89(12):6758-6765. PubMed ID: 28505421
[TBL] [Abstract][Full Text] [Related]
25. Urinary Amine Metabolomics Characterization with Custom 12-Plex Isobaric DiLeu Labeling.
Wei P; Hao L; Thomas S; Buchberger AR; Steinke L; Marker PC; Ricke WA; Li L
J Am Soc Mass Spectrom; 2020 Sep; 31(9):1854-1860. PubMed ID: 32678615
[TBL] [Abstract][Full Text] [Related]
26. Dansylation of unactivated alcohols for improved mass spectral sensitivity and application to analysis of cytochrome P450 oxidation products in tissue extracts.
Tang Z; Guengerich FP
Anal Chem; 2010 Sep; 82(18):7706-12. PubMed ID: 20795636
[TBL] [Abstract][Full Text] [Related]
27. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
Shen W; Han W; Li Y; Meng Z; Cai L; Li L
Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
[TBL] [Abstract][Full Text] [Related]
29. Bladder cancer biomarker screening based on non-targeted urine metabolomics.
Li J; Cheng B; Xie H; Zhan C; Li S; Bai P
Int Urol Nephrol; 2022 Jan; 54(1):23-29. PubMed ID: 34850327
[TBL] [Abstract][Full Text] [Related]
30. Counting missing values in a metabolite-intensity data set for measuring the analytical performance of a metabolomics platform.
Huan T; Li L
Anal Chem; 2015 Jan; 87(2):1306-13. PubMed ID: 25496403
[TBL] [Abstract][Full Text] [Related]
31. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
32. Stable isotope N-phosphoryl amino acids labeling for quantitative profiling of amine-containing metabolites using liquid chromatography mass spectrometry.
Zhang S; Shi J; Shan C; Huang C; Wu Y; Ding R; Xue Y; Liu W; Zhou Q; Zhao Y; Xu P; Gao X
Anal Chim Acta; 2017 Jul; 978():24-34. PubMed ID: 28595723
[TBL] [Abstract][Full Text] [Related]
33. Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
Wang R; Kang H; Zhang X; Nie Q; Wang H; Wang C; Zhou S
BMC Cancer; 2022 Feb; 22(1):214. PubMed ID: 35220945
[TBL] [Abstract][Full Text] [Related]
34. 5-Diethylamino-naphthalene-1-sulfonyl chloride (DensCl): a novel triplex isotope labeling reagent for quantitative metabolome analysis by liquid chromatography mass spectrometry.
Zhou R; Guo K; Li L
Anal Chem; 2013 Dec; 85(23):11532-9. PubMed ID: 24200037
[TBL] [Abstract][Full Text] [Related]
35. High-Performance Chemical Isotope Labeling Liquid Chromatography-Mass Spectrometry for Profiling the Metabolomic Reprogramming Elicited by Ammonium Limitation in Yeast.
Luo X; Zhao S; Huan T; Sun D; Friis RM; Schultz MC; Li L
J Proteome Res; 2016 May; 15(5):1602-12. PubMed ID: 26947805
[TBL] [Abstract][Full Text] [Related]
36. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
37. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
[TBL] [Abstract][Full Text] [Related]
38. High-Coverage Quantitative Metabolomics of Human Urine: Effects of Freeze-Thaw Cycles on the Urine Metabolome and Biomarker Discovery.
Chen D; Chan W; Zhao S; Li L; Li L
Anal Chem; 2022 Jul; 94(27):9880-9887. PubMed ID: 35758637
[TBL] [Abstract][Full Text] [Related]
39. [Determination of eight environmental phenols in human urine samples by high-throughput solid-phase extraction-ultra-performance liquid chromatography-tandem mass spectrometry].
Lin X; Qiu T; Zhang X; Hu X; Yang Y; Zhu Y
Se Pu; 2020 Dec; 38(12):1456-1464. PubMed ID: 34213261
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
